Cached score snapshot
US.TECH · Bio-Techne
110分制 54.8/110;5D動能v2 1/50;排序分 55.8/160
Score breakdown
避免
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +1.15% | -0.44% / +3.37% | 65% | 1.3% | Actual outcome pending · 1 / 3 bars observed |
| 30D observation | +9.07% | -0.01% / +15.60% | 75% | 8.8% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | +1.02% | -0.80% / +3.30% | 64.4% | 1.9% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-06-12 → 2026-10-20 · 90 archived points · 2 Improving turn signal · 6 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 21.1 · 市場環境 12.2 · 5D動能v2 1
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 2.5/5 · 較差
Sub-items
資金流 — 5.2/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 12.2/15 · 優秀
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 7.8/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 21.1/30 · 良好
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 4/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 2.5/5分 資金流分析總分: 5.2/20分 市場環境分析總分: 12.2/15分 催化劑分析: 2/20分 風險管理總分: 7.8/10分 技術信號分析總分: 21.1/30分 情緒分析: 4/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.6,
"details": {
"atrPct": 0.24007744433688286,
"turnoverUsdM": 148.91427397,
"liquidityPoints": 0.4,
"volatilityPoints": 1.2
}
},
"rrPoints": 1.8,
"stopLevels": {
"symbol": "US.TECH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 71.9628,
"strength_details": {
"ma_score": 2,
"atr_score": 2.5,
"rsi_score": 2,
"macd_score": 1.5,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 5,
"stop_loss_percent": 0.5,
"take_profit_price": 75.9255,
"target_multiplier": 1.9,
"technical_strength": 1.75,
"take_profit_percent": 5
},
"positionPoints": 1.6,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.6666666666666667,
"stopLossPercent": 3,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 55.8,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 54.8,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 1
},
"market": {
"ma20": 72.327,
"ma50": 71.8724,
"close": 72.31,
"prevClose": 72.43,
"avgVolume20": 2346639,
"volumeRatio": 0.88,
"changePercent": -0.17
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 1,
"details": {
"ret_5d": 0,
"max_score": 50,
"max_total": 50,
"raw_total": 1,
"vcp_bonus": 0,
"vol_ratio": 0.8543242295829366,
"ret_points": 0,
"vol_points": 0,
"range_ratio": 0.7905627396957391,
"volat_points": 0,
"day_range_pct": 0.0023509887982296708,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 1,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 55.8,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 2.5,
"label": "基本面",
"weight": "5/110",
"normalized": 50,
"contribution": 2.5
},
{
"raw": 5.2,
"label": "資金流",
"weight": "20/110",
"normalized": 26,
"contribution": 5.2
},
{
"raw": 12.2,
"label": "市場環境",
"weight": "15/110",
"normalized": 81.33,
"contribution": 12.2
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 7.8,
"label": "風險管理",
"weight": "10/110",
"normalized": 78,
"contribution": 7.8
},
{
"raw": 21.1,
"label": "技術信號",
"weight": "30/110",
"normalized": 70.33,
"contribution": 21.1
},
{
"raw": 4,
"label": "情緒分析",
"weight": "10/110",
"normalized": 40,
"contribution": 4
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "避免",
"result": 54.8,
"details": [
"基本面分析總分: 2.5/5分",
"資金流分析總分: 5.2/20分",
"市場環境分析總分: 12.2/15分",
"催化劑分析: 2/20分",
"風險管理總分: 7.8/10分",
"技術信號分析總分: 21.1/30分",
"情緒分析: 4/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 2.5,
"資金流": 5.2,
"市場環境": 12.2,
"情緒分析": 4,
"技術信號": 21.1,
"風險管理": 7.8
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 4,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.2,
"pePoints": 0.2,
"epsPoints": 0,
"roePoints": 0,
"debtPoints": 0.5,
"marginPoints": 0.4,
"turnoverUsdM": 148.91427397,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0.3,
"marketCapPoints": 0.4
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 0.8,
"obvPoints": 0.8,
"vwapPoints": 0.8,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.TECH",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "優秀",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 15.3
}
},
"trend": {
"score": 3.4,
"details": {
"qqq": {
"ma20": 717.3850005500001,
"ma50": 711.3217994399997,
"name": "QQQ",
"close": 718.35999,
"points": 2
},
"spy": {
"ma20": 768.6994929500001,
"ma50": 757.5966012200001,
"name": "SPY",
"close": 765.96002,
"points": 1.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 0.24007744433688286,
"atrPoints": 4,
"cciPoints": 2.4,
"vixPoints": 2.4,
"marketTrendPoints": 3.4
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 4,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 4,
"negativeHits": 0,
"positiveHits": 1,
"sentimentScoreRaw": 0.6
}
},
"sentimentData": {
"raw": [
{
"id": 141365716,
"url": "https://finnhub.io/api/news?id=a5ef3603445d8aa9a0dd109ccf0a962292f51f02adabd49ffa75d0ac6f6393df",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.",
"category": "company",
"datetime": 1788214120,
"headline": "Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks"
},
{
"id": 141206752,
"url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
"category": "company",
"datetime": 1786626060,
"headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
},
{
"id": 141204891,
"url": "https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1786535402,
"headline": "Techne (TECH) Q4 Earnings Meet Estimates"
},
{
"id": 141202745,
"url": "https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.",
"category": "company",
"datetime": 1786534647,
"headline": "Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"
}
],
"raw_source": [
{
"id": 141949006,
"url": "https://finnhub.io/api/news?id=00df6df6df67101935570b3d09b4f6fb117c7f4bf5fcbd493dfc9d008f76108f",
"image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
"source": "ChartMill",
"related": "TECH",
"summary": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session.",
"category": "company",
"datetime": 1788870900,
"headline": "These S&P500 stocks are moving in today's pre-market session"
},
{
"id": 141365715,
"url": "https://finnhub.io/api/news?id=ee3edec51f2a0769452f44c0254fa97b00f03c804dffd9bcb7fd5748b9ec87a4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant progress toward its climate and sustainability objectives, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi) and substantial reductions in operational emissions during fiscal year 2026.",
"category": "company",
"datetime": 1788262200,
"headline": "Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals"
},
{
"id": 141371333,
"url": "https://finnhub.io/api/news?id=530e9947363819acf6e2f8d541c54ea3bd19cbcc5e4b1a633a9b1554f43e1d1f",
"image": "",
"source": "Benzinga",
"related": "TECH",
"summary": "Fiscal 2026 highlights:Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targetsMarket-based Scope 1 and 2 emissions reduced 49% year-over-yearMore than half of the",
"category": "company",
"datetime": 1788244574,
"headline": "Bio-Techne Announces SBTi Validation Of 70% Scope 1 & 2 Emissions Reduction Target By FY2031 And Supplier Engagement Commitment, Reporting Significant Operational Emissions Cuts In FY2026"
},
{
"id": 141365716,
"url": "https://finnhub.io/api/news?id=a5ef3603445d8aa9a0dd109ccf0a962292f51f02adabd49ffa75d0ac6f6393df",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.",
"category": "company",
"datetime": 1788214120,
"headline": "Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks"
},
{
"id": 141326656,
"url": "https://finnhub.io/api/news?id=f0ee289a15577c07a4f88b461b3b9df0cab874642345723232053d6898832f08",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "TECH",
"summary": "Ruane, Cunniff & Goldfarb Q2 2026 13F: key holdings, new buys & trims, and Sequoia Fund vs S&P 500. Read here for a detailed investment analysis.",
"category": "company",
"datetime": 1787781184,
"headline": "Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update"
},
{
"id": 141365510,
"url": "https://finnhub.io/api/news?id=db75d1ced2a8c3d0024bd9d7d5a4f5c9b286c68130e8836fd45d69e34e43e3f5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.",
"category": "company",
"datetime": 1787741713,
"headline": "1 Surging Stock for Long-Term Investors and 2 That Underwhelm"
},
{
"id": 141351198,
"url": "https://finnhub.io/api/news?id=2adf4bf7dafa87a5d2a094ed6a61a6bf2425c55fc959d4ac16ad5c7df45ef494",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
"category": "company",
"datetime": 1787567376,
"headline": "1 Profitable Stock to Own for Decades and 2 We Turn Down"
},
{
"id": 141279422,
"url": "https://finnhub.io/api/news?id=6923c1cc8f112e10dd5ad9d09823f56d409c83dd9e29bc30f7d851606e748f6b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.",
"category": "company",
"datetime": 1787326260,
"headline": "Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?"
},
{
"id": 141285994,
"url": "https://finnhub.io/api/news?id=daf4a629089d8f9e095f46c70670711c9ee0c32ab5dca24482a04c58e554bb62",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Bio-Techne has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.",
"category": "company",
"datetime": 1787050238,
"headline": "Is Wall Street Bullish or Bearish on Bio-Techne Stock?"
},
{
"id": 141285995,
"url": "https://finnhub.io/api/news?id=9d830f74e586b86a2df937c7d17ccf401031341507955ec275356e50261935d3",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.",
"category": "company",
"datetime": 1787007020,
"headline": "3 High-Flying Stocks We Approach with Caution"
},
{
"id": 141219177,
"url": "https://finnhub.io/api/news?id=9dc21aea1bd671a42c17cf25683ce0b07533c7514480b856f307022b024fa85f",
"image": "",
"source": "Benzinga",
"related": "TECH",
"summary": "Wells Fargo analyst Brandon Couillard downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $62 to $73.",
"category": "company",
"datetime": 1786642576,
"headline": "Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73"
},
{
"id": 141206752,
"url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
"category": "company",
"datetime": 1786626060,
"headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
},
{
"id": 141204890,
"url": "https://finnhub.io/api/news?id=9406225dd488595e8f2ad879c7709d8811f292e4cdbc3e751afe48f8f25b325b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026. The correct shareholder of record date is August 24, 2026. All other information contained in the dividend announcement remains unchanged.",
"category": "company",
"datetime": 1786617000,
"headline": "Bio-Techne Corrects Dividend Announcement"
},
{
"id": 141204891,
"url": "https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1786535402,
"headline": "Techne (TECH) Q4 Earnings Meet Estimates"
},
{
"id": 141202745,
"url": "https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.",
"category": "company",
"datetime": 1786534647,
"headline": "Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"
},
{
"id": 141202747,
"url": "https://finnhub.io/api/news?id=a7e01a424982cbf1b9eefe452d652dad9b4a7c63f36785bac63834e8044fbfcd",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders of record on August 17, 2026. Future cash dividends will be considered by the Board of Directors on a quarterly basis.",
"category": "company",
"datetime": 1786530600,
"headline": "Bio-Techne Declares Dividend"
},
{
"id": 141202746,
"url": "https://finnhub.io/api/news?id=c0f2ff78f72475d1797326fe1bba1f4f571bb5e8d8efbe477118d9131dfd087d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "TECH",
"summary": "Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026.",
"category": "company",
"datetime": 1786530600,
"headline": "Bio-Techne Releases Fourth Quarter Fiscal 2026 Results"
},
{
"id": 141197930,
"url": "https://finnhub.io/api/news?id=bc376ed2ba05725913becda94402bfb8027c2f2b313a98323c8553dc2a67c224",
"image": "",
"source": "Benzinga",
"related": "TECH",
"summary": "Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year. The",
"category": "company",
"datetime": 1786516866,
"headline": "Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 4,
"negative_hits": 0,
"positive_hits": 1,
"recomputed_at_score": true,
"sentiment_score_raw": 0.6,
"source_article_count": 18,
"discarded_article_count": 14
},
"sentimentPoints": 4
}
},
"技術信號": {
"max": 30,
"raw": 21.1,
"grade": "良好",
"items": {
"bbPoints": 2.4,
"adxPoints": 3,
"sarPoints": 1.7999999999999998,
"vcpPoints": 3,
"macdPoints": 2.4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 3,
"vcp_reason": "波幅收縮(1.4%→0.6%);量縮(v10/v30=0.64);跌縮量(近10日5日);站上MA50;Ready=Y;Confirm=N",
"vcp_metrics": {
"up_days": 4,
"vol_ref": 3071610,
"down_days": 5,
"vcp_ready": true,
"above_ma50": true,
"avg_vol_10": 1975930,
"avg_vol_20": 2410545,
"avg_vol_30": 3071610,
"range_pct_10": 0.006084912183653681,
"range_pct_20": 0.008574194440603021,
"range_pct_30": 0.014382519706817953,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": true,
"down_shrink_ok": true,
"up_expand_days": 0,
"breakout_20d_ok": false,
"vol_ratio_10_30": 0.6432880476362559,
"dist_to_20d_high": 0.004268796474800361,
"down_shrink_days": 5,
"breakout_level_20d": 72.62,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.42307692307691835
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": true
},
"kdjAdxPoints": 0.7,
"rsiKdjPoints": 3.2,
"volumeWeight": 2,
"maCrossPoints": 2.4,
"shortRsiPoints": 0.4,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0.6,
"volumePointsTechnical": 0.8
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.6,
"details": {
"atrPct": 0.24007744433688286,
"turnoverUsdM": 148.91427397,
"liquidityPoints": 0.4,
"volatilityPoints": 1.2
}
},
"rrPoints": 1.8,
"stopLevels": {
"symbol": "US.TECH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 71.9628,
"strength_details": {
"ma_score": 2,
"atr_score": 2.5,
"rsi_score": 2,
"macd_score": 1.5,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 5,
"stop_loss_percent": 0.5,
"take_profit_price": 75.9255,
"target_multiplier": 1.9,
"technical_strength": 1.75,
"take_profit_percent": 5
},
"positionPoints": 1.6,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.6666666666666667,
"stopLossPercent": 3,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 71.43,
"atr": {
"atr": 0.1736,
"rule": "ATR / current price; lower volatility scores higher",
"score": 8,
"atr_pct": 0.24
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "平衡",
"score": 6,
"value": 17.13
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.1483
},
"kdj": {
"d": 47.5,
"j": 50.85,
"k": 48.62,
"rule": "Cursor_18.24 K/D cross",
"score": 4,
"signal": "金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "超賣或超買風險",
"score": 2,
"value": 37.05
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 2,
"trend": "資金流出",
"value": 67935713,
"recentSlope": -338128.7,
"previousSlope": -5680
},
"rsi": 53.06,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 6,
"trend": "下降",
"value": 72.5003,
"position": "SAR接近價",
"distancePct": 0.26,
"previousTrend": "下降"
},
"ma50": 71.8724,
"macd": {
"macd": 0.41023369370164176,
"trend": "中性偏多",
"signal": 0.572200037810684,
"histogram": -0.1619663441090422
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 2,
"value": 72.3311,
"position": "<VWAP",
"consecutiveAbove": 0
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "無力",
"ratio": 0.88,
"score": 4,
"avgVolume": 2346639,
"currentVolume": 2059387
},
"derived": {
"ma20": 72.327,
"ma50": 71.8724,
"prevClose": 72.43,
"avgVolume10": 1981709,
"avgVolume20": 2346639,
"changePercent": -0.17,
"avgVolumeForScore": 2346639
},
"ma_cross": {
"ma20": 72.327,
"ma50": 71.8724,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "接近",
"score": 6,
"prevMa20": 72.3175,
"prevMa50": 71.8462,
"spreadPct": 0.63,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 72.133,
"upper": 72.521,
"position": "中間"
},
"rsi_short": 46.55,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 0.88
}
}
}
Raw metrics JSON
{
"close": 72.31,
"volume": 2059387,
"changePercent": -0.17
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.